Search results for "DETECT"

showing 10 items of 5902 documents

Direct visualization of oral-cavity tissue fluorescence as novel aid for early oral cancer diagnosis and potentially malignant disorders monitoring.

2011

Direct visualization of the oral tissue autofluorescence has been recently reviewed in several studies as a possible adjunctive tool for early recognition and diagnosis of potentially malignant and malignant oral disorders. The aims of this study were to assess: a) the value of a simple handheld device for tissue auto-fluorescence visualization of potentially malignant oral lesions; and b) the sensitivity, specificity and diagnostic accuracy of tested device, using histological examination as the gold standard. 175 consecutive patients, with at least one clinical oral lesion, were enrolled in the study. Clinical conventional inspections were performed for each patient by two blind operator…

AdultMaleMild DysplasiaPathologymedicine.medical_specialtyEpithelial dysplasiaImmunologySettore MED/50 - Scienze Tecniche Mediche ApplicateautofluorescenceFluorescenceYoung Adultoral lichen planusPredictive Value of TestsOPMD fluorescenceSettore MED/28 - Malattie OdontostomatologicheBiopsyepithelial dysplasiamedicineHumansImmunology and AllergyEarly Detection of CancerAgedLeukoplakiaAged 80 and overPharmacologyMouthmedicine.diagnostic_testbusiness.industryDiagnosis OralMiddle Agedoral cancermedicine.diseaseautofluorescence; epithelial dysplasia; leukoplakia; oral cancer; oral lichen planus;stomatognathic diseasesDysplasialeukoplakiaFemaleMouth NeoplasmsHistopathologyOral lichen planusbusinessPrecancerous ConditionsOral medicine
researchProduct

The link between mitochondrial DNA hypervariable segment I heteroplasmy and ageing among genetically unrelated Latvians

2011

International audience; Various studies have demonstrated that mitochondrial DNA (mtDNA) heteroplasmy tends to increase with age and that the observed frequency of heteroplasmy among populations mostly depends on the way it is measured. Therefore, we investigated age-related association on the presence of mtDNA heteroplasmy within the hypervariable segment 1 (HVS-I) in a selected study group. The study group consisted of 300 maternally unrelated Latvians ranging in age from 18 to over 90years. To determine the optimal method for mtDNA heteroplasmy detection, three approaches were used: (i) SURVEYORTM Mutation Detection Kit, (ii) sequencing and (iii) denaturing gradient-gel electrophoresis (…

AdultMaleMitochondrial DNAAgingAdolescentBiologyBiochemistryDNA MitochondrialBroad spectrumYoung AdultEndocrinologyLatviansGeneticsHumansMutation detectionheteroplasmydetection of mtDNA heteroplasmyMolecular BiologyAgedGeneticsAged 80 and overDenaturing Gradient Gel ElectrophoresismtDNA[SDV.MHEP.GEG]Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologyCell BiologySequence Analysis DNAMiddle AgedLatviaHeteroplasmyAgeingageingMutationFemaleHuman mitochondrial DNA haplogroup
researchProduct

Memory detection using fMRI - does the encoding context matter?

2015

Recent research revealed that the presentation of crime related details during the Concealed Information Test (CIT) reliably activates a network of bilateral inferior frontal, right medial frontal and right temporal-parietal brain regions. However, the ecological validity of these findings as well as the influence of the encoding context are still unclear. To tackle these questions, three different groups of subjects participated in the current study. Two groups of guilty subjects encoded critical details either only by planning (guilty intention group) or by really enacting (guilty action group) a complex, realistic mock crime. In addition, a group of informed innocent subjects encoded hal…

AdultMaleMultivariate analysisDeceptionEcological validityCognitive NeuroscienceLie DetectionPrefrontal CortexContext (language use)Functional LateralityNeural activityYoung AdultMemoryEncoding (memory)Parietal LobeImage Processing Computer-AssistedHumansBrain MappingUnivariateRecognition PsychologyGalvanic Skin ResponseMagnetic Resonance ImagingTest (assessment)NeurologyAction (philosophy)GuiltFemaleCrimeNerve NetPsychologySocial psychologyPsychomotor PerformanceCognitive psychologyNeuroImage
researchProduct

Metabolomics provide new insights on lung cancer staging and discrimination from chronic obstructive pulmonary disease

2014

Chronic obstructive pulmonary disease (COPD) and lung cancer are widespread lung diseases. Cigarette smoking is a high risk factor for both the diseases. COPD may increase the risk of developing lung cancer. Thus, it is crucial to be able to distinguish between these two pathological states, especially considering the early stages of lung cancer. Novel diagnostic and monitoring tools are required to properly determine lung cancer progression because this information directly impacts the type of the treatment prescribed. In this study, serum samples collected from 22 COPD and 77 lung cancer (TNM stages I, II, III, and IV) patients were analyzed. Then, a collection of NMR metabolic fingerprin…

AdultMaleOncologymedicine.medical_specialtyLung NeoplasmsMagnetic Resonance SpectroscopyClinical BiochemistryPharmaceutical ScienceCreatineAnalytical ChemistryDiagnosis DifferentialPulmonary Disease Chronic Obstructivechemistry.chemical_compoundPredictive Value of TestsCarcinoma Non-Small-Cell LungInternal medicineDrug DiscoveryBiomarkers TumormedicineHumansMetabolomicsLeast-Squares AnalysisRisk factorLung cancerLungPathologicalEarly Detection of CancerSpectroscopyAgedNeoplasm StagingAged 80 and overUnivariate analysisCOPDLungChemistryDiscriminant AnalysisMiddle AgedPrognosismedicine.diseaserespiratory tract diseasesmedicine.anatomical_structureMultivariate AnalysisDisease ProgressionFemaleLung cancer stagingJournal of Pharmaceutical and Biomedical Analysis
researchProduct

PCA3 as a second-line biomarker in a prospective controlled randomized opportunistic prostate cancer screening programme

2017

Objectives: PCA3 performance as a single second line biomarker is compared to the European Randomised Study of Screening for Prostate Cancer risk calculator model 3 (ERSPC RC-3) in an opportunistic screening in prostate cancer (PCa). Material and methods: 5,199 men, aged 40-75y, underwent prostate-specific antigen (PSA) screening and digital rectal examination (DRE). Men with a normal DRE and PSA >= 3 ng/ml had a PCA3 test done. All men with PCA3 >= 35 underwent an initial biopsy (IBx) 12 cores. Men with PCA3 = 3 ng/ml and DRE is normal, IBx could be avoided in 12.5% less than if ERSPC RC-3 is used and would reduce the false negative cases by 36.2%. At a FU of 21.7 months, this dual protoco…

AdultMalePCA3medicine.medical_specialty030232 urology & nephrologyUrologyurologic and male genital diseaseslaw.inventionOpportunistic screening03 medical and health sciencesProstate cancerPSA0302 clinical medicineSecond lineRandomized controlled trialAntigens NeoplasmlawBiopsyBiomarkers TumormedicineHumansProspective StudiesEarly Detection of CancerAgedGynecologyProstate cancermedicine.diagnostic_testbusiness.industryProstatic NeoplasmsGeneral MedicineRectal examinationMiddle Agedmedicine.diseaseProstate cancer screening030220 oncology & carcinogenesisBiomarker (medicine)PCA3business
researchProduct

Survival of Adults with Acute Lymphoblastic Leukemia in Germany and the United States

2014

BackgroundAdulthood acute lymphoblastic leukemia (ALL) is a rare disease. In contrast to childhood ALL, survival for adults with ALL is poor. Recently, new protocols, including use of pediatric protocols in young adults, have improved survival in clinical trials. Here, we examine population level survival in Germany and the United States (US) to gain insight into the extent to which changes in clinical trials have translated into better survival on the population level.MethodsData were extracted from the Surveillance, Epidemiology, and End Results database in the US and 11 cancer registries in Germany. Patients age 15-69 diagnosed with ALL were included. Period analysis was used to estimate…

AdultMalePediatricsmedicine.medical_specialtyAdolescentNon-Clinical MedicineEpidemiologyScienceLymphoblastic LeukemiaBiostatisticsHematologic Cancers and Related DisordersGermanyLeukemiasEpidemiologyHumansMedicineStatistical MethodsYoung adultSurvival analysisAgedHealth Care PolicyMultidisciplinaryRelative survivalbusiness.industryStatisticsQRCancers and NeoplasmsCancerHematologyMiddle AgedPrecursor Cell Lymphoblastic Leukemia-LymphomaAcute Lymphoblastic Leukemiamedicine.diseaseSurvival AnalysisUnited StatesClinical trialOncologyUnited States ; age groups ; cancer treatment ; German people ; Germany ; cancer detection and diagnosis ; acute lymphoblastic leukemia ; leukemiasMedicineFemaleHealth StatisticsbusinessMathematicsResearch ArticleRare diseasePLoS ONE
researchProduct

Cumyl-PEGACLONE: A comparatively safe new synthetic cannabinoid receptor agonist entering the NPS market?

2018

AdultMalePharmaceutical SciencePharmacology01 natural sciencesAnalytical ChemistryDesigner Drugs03 medical and health sciencesYoung Adult0302 clinical medicineEnvironmental ChemistryMedicineHumans030216 legal & forensic medicineSpectroscopyCannabinoid Receptor AgonistsPsychotropic Drugsbusiness.industryIllicit Drugs010401 analytical chemistrySynthetic cannabinoid receptor agonistMiddle Aged0104 chemical sciencesSubstance Abuse DetectionSubstance Abuse DetectionFemalebusinessCarbolinesDrug testing and analysis
researchProduct

Automated Determination of Fluvoxamine in Plasma by Column-Switching High-Performance Liquid Chromatography

1992

Abstract A column-switching system with high-performance liquid-chromatographic separation and ultraviolet detection is described for automated determination of fluvoxamine in human plasma or serum. Samples were injected and the drug was retained in a clean-up column [20 x 4.6 mm (i.d.)] filled with C8 reversed-phase material (10-micron particles). After unwanted material was washed out, the drug was eluted and separated with an analytical chromatography column, 4.6 x 250 mm (i.d.), filled with Nucleosil 100 CN (5-micron particles) with an acetonitrile:methanol:0.01 mol/L phosphate buffer eluent (188:578:235 by vol) at a flow rate of 1.5 mL/min for < 20 min and detected by spectromet…

AdultMaleQuality ControlDetection limitAutoanalysisChromatographyDepressionChemistryElutionBiochemistry (medical)Clinical BiochemistryFluvoxamineMiddle AgedMass spectrometryHigh-performance liquid chromatographyColumn chromatographyFluvoxaminemedicineHumansFemaleChromatography columnQuantitative analysis (chemistry)Chromatography High Pressure LiquidAgedmedicine.drugClinical Chemistry
researchProduct

Automated Determination of Dextromethorphan and Its Main Metabolites in Human Plasma by High-Performance Liquid Chromatography and Column Switching

1996

An automated column-switching technique coupled to isocratic high-performance liquid chromatography (HPLC) with fluorescence detection was developed for simultaneous determination of dextromethorphan and its three major metabolites, dextrorphan, hydroxymorphinan, and methoxymorphinan. After cleavage of conjugates by incubation with glucuronidasearylsulfatase at 37 degrees C for 15 h, plasma samples were injected directly into the HPLC system. Dextromethorphan and metabolites were retained on a cleanup column (10 x 4.6 mm internal diameter [ID]) filled with cyanopropyl (CN) material (Hypersil CPS, 10-microns article size) while interfering proteins and lipids were washed to waste. After colu…

AdultMaleQuality ControlMetaboliteMass spectrometryDextromethorphanHigh-performance liquid chromatographyFluorescence spectroscopychemistry.chemical_compoundDextrorphanmedicineHumansPharmacology (medical)BiotransformationChromatography High Pressure LiquidPharmacologyDetection limitChromatographyElutionDextromethorphanAntitussive AgentsPhenotypeSpectrometry FluorescenceCytochrome P-450 CYP2D6chemistryCalibrationRegression AnalysisFemalemedicine.drugTherapeutic Drug Monitoring
researchProduct

Detection of gamma-hydroxybutyrate in hair: Validation of GC–MS and LC–MS/MS methods and application to a real case

2012

A gas chromatography-mass spectrometry (GC-MS) and a liquid chromatography tandem mass spectrometry (LC-MS/MS) method were validated for quantifying endogenous and exogenous hair concentrations of gamma-hydroxybutyrate (GHB). The GC-MS method is based on overnight extraction of 25 mg hair in NaOH at 56 °C, liquid/liquid extraction in ethylacetate and trimethylsylil derivatization; analysis is by electron ionization and single ion monitoring of three ions. The LC-MS/MS method entails a rapid digestion of 25 mg hair with NaOH at 75 °C for 40 min, liquid/liquid extraction in ethylacetate and reconstitution of the extract in the LC mobile phase; negative ion electrospray ionization and multiple…

AdultMaleQuality ControlSpectrometry Mass Electrospray IonizationSubstance-Related DisordersElectrospray ionizationClinical BiochemistryLiquid-Liquid ExtractionPharmaceutical ScienceAcetatesTandem mass spectrometryMass spectrometryGas Chromatography-Mass SpectrometryAnalytical ChemistryForensic ToxicologySettore MED/43 - Medicina LegaleLiquid chromatography–mass spectrometryLimit of DetectionTandem Mass SpectrometryDrug DiscoveryHumansSodium HydroxideSpectroscopyDetection limitChromatographyChemistryIllicit DrugsSelected reaction monitoringHair Segmental analysis GC–MS LC–MS/MSTemperatureReproducibility of ResultsGamma hydroxybutyrateReference StandardsSubstance Abuse DetectionGamma-hydroxybutyrate GHBCalibrationLinear ModelsCrimeGas chromatography–mass spectrometrySodium OxybateChromatography LiquidHair
researchProduct